KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Non-Current Liabilities: 2009-2024

Historic Total Non-Current Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $630.2 million.

  • Idexx Laboratories' Total Non-Current Liabilities fell 20.70% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $573.7 million, marking a year-over-year decrease of 20.70%. This contributed to the annual value of $630.2 million for FY2024, which is 23.50% down from last year.
  • As of FY2024, Idexx Laboratories' Total Non-Current Liabilities stood at $630.2 million, which was down 23.50% from $823.8 million recorded in FY2023.
  • Idexx Laboratories' Total Non-Current Liabilities' 5-year high stood at $1.1 billion during FY2020, with a 5-year trough of $630.2 million in FY2024.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $823.8 million (2023), whereas its average is $785.4 million.
  • Per our database at Business Quant, Idexx Laboratories' Total Non-Current Liabilities climbed by 16.11% in 2020 and then dropped by 23.50% in 2024.
  • Idexx Laboratories' Total Non-Current Liabilities (Yearly) stood at $1.1 billion in 2020, then fell by 8.84% to $983.6 million in 2021, then dropped by 8.28% to $902.2 million in 2022, then declined by 8.69% to $823.8 million in 2023, then declined by 23.50% to $630.2 million in 2024.